
Citaswiss 250mg Injection
Marketer
Swiss Parenterals Ltd
Salt Composition
Citicoline (250mg)
Overview Citaswiss 250mg Injection
Citichol 250mg Injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's-related memory impairment (dementia). It safeguards brain neurons from damage and facilitates their repair, thereby enhancing cognitive function. Administered intravenously by a healthcare professional only—never self-inject—it's indicated when oral intake is infeasible. Follow your doctor's prescribed dosage and schedule; if a dose is missed, take it promptly. Potential side effects include hypotension, abdominal discomfort, diarrhea, cardiac arrhythmia, skin rash, sleep disturbances, and worsening numbness in affected limbs. Injection site reactions (pain, erythema, swelling) may also occur but are generally transient. Report persistent or bothersome effects to your physician. Prior to treatment, disclose any kidney issues, seizure history (epilepsy), and current medications. Dosage is tailored to age and condition. Pregnancy, breastfeeding, or pregnancy intentions must be reported before initiating therapy.
Uses of Citaswiss 250mg Injection
Managing Stroke | Head Trauma Care | Alzheimer's Disease Management | Dementia in Parkinson's Disease Treatment
Major Benefits of Citaswiss 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Citaswiss 250mg Injection:
- Injection site reactions (pain, swelling, redness)
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Citaswiss 250mg Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
How Citaswiss 250mg Injection works:
Neuro-Guard 250mg Injection safeguards nerve tissue. It fosters nerve cell health, shielding them from injury and enhancing their viability through the generation of key neurochemicals such as phosphatidylcholine and acetylcholine. Furthermore, it mitigates the accumulation of free fatty acids at nerve injury sites.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Consuming alcohol while using Citaswiss 250mg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citaswiss 250mg Injection in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Citaswiss 250mg Injection with breastfeeding is currently lacking. Seek professional medical advice.
DrivingCONSULT YOUR DOCTOR
The effect of Citaswiss 250mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with kidney impairment should use Citaswiss 250mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Citaswiss 250mg Injection to individuals with hepatic impairment is scarce. Seek medical advice from your physician.
What if you forget to take Citaswiss 250mg Injection :
NA
Facts to Know About Citaswiss 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Diphosphate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Active Class | Cognitive enhancer |
